Showing results (51-60 of 161) with videos related to

Sort By:
Pageof 17
Oncotarget|October 6, 2017
Therapeutic efficacy of SYM004, a mixture of two anti-EGFR antibodies in human colorectal cancer with acquired resistance to cetuximab and MET activationStefania Napolitano, Giulia Martini, Erika Martinelli, et al.
Frontiers in Oncology|February 6, 2025
Trifluridine/tipiracil regimen in combination with bevacizumab for metastatic colorectal cancer in the third line: an expert opinionCarmine Pinto, Sara Lonardi, Evaristo Maiello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Antitumor activity of ZD6474, a vascular endothelial growth factor-2 and epidermal growth factor receptor small molecule tyrosine kinase inhibitor, in combination with SC-236, a cyclooxygenase-2 inhibitorConcetta Tuccillo, Marco Romano, Teresa Troiani, et al.
Cancer Treatment Reviews|March 13, 2022
Immunotherapy in advanced anal cancer: Is the beginning of a new era?Davide Ciardiello, Luigi Pio Guerrera, Brigida Anna Maiorano, et al.
Frontiers in Oncology|March 2, 2023
Efficacy and safety of a biomarker-driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with <i>RAS/BRAF</i> wild type tumors at start of first line: The CAPRI 2 GOIM trialGiulia Martini, Davide Ciardiello, Stefania Napolitano, et al.
Oncotarget|April 19, 2017
Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFRCarminia Maria Della Corte, Umberto Malapelle, Elena Vigliar, et al.
Clinical Colorectal Cancer|February 1, 2022
Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survivalDavide Ciardiello, Vincenzo Famiglietti, Stefania Napolitano, et al.
Oncology Reports|August 4, 2004
Pegylated liposomal doxorubicin: pharmacologic and clinical evidence of potent antitumor activity with reduced anthracycline-induced cardiotoxicity (review)Michele Orditura, Fabiana Quaglia, Floriana Morgillo, et al.
Cancer|January 13, 2004
Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinomaFerdinando De Vita, Michele Orditura, Eva Lieto, et al.
Updates in Surgery|January 28, 2026
Radiomics of portal-phase ring enhancement: a novel imaging biomarker for bevacizumab response associated with overall survival rates. It might help with surgical decision-making in colorectal liver metastases?Maria Chiara Brunese, Alfredo Clemente, Marco De Chiara, et al.
Pageof 17